BOTHE.BR - Bone Therapeutics SA

Valuation of Bone Therapeutics SA(BOTHE.BR), Bone Therapeutics SA, a biotechnology company, engages in the development of cell therapy products f

Bone Therapeutics SA

BOTHE.BR

EURONEXT

Inactive Equity

Bone Therapeutics SA, a biotechnology company, engages in the development of cell therapy products for orthopedics and bone diseases. Its products include ALLOB, an allogeneic cell therapy product, which is in Phase I/IIa clinical trial for the treatment of delayed-union fractures and lumbar spinal fusion; and JTA-004, an intra-articular injectable that is in phase III clinical trial to treat osteoarthritic pain in the knee. Bone Therapeutics SA was incorporated in 2006 and is based in Mont-Saint-Guibert, Belgium.

0.29 EUR

0 (0%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

Valuation Date:

Oct 26, 2022 10:35 AM

Share Price on Valuation Date

$0.29

Stock Beta

0.302952

Shares Outstanding

FMP

Home Terms of Service Privacy Policy Blog Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.